Lower depression levels during the COVID pandemic, study from India finds

21 Oct 2021

Depression levels have reduced during the COVID-19 pandemic in a group of 449 people with epilepsy, a new study from India has found.

The research, published in Epilepsy & Behavior journal, aimed to assess the impact of the pandemic on seizure control, depression status and medicine adherence, given that healthcare services have been disrupted.

The study evaluated 449 people with epilepsy, who had previously been assessed for depression in New Delhi, India, over the phone. They were asked about their epilepsy medicines, seizures, depression and suicidal thoughts in the last six months.

The results showed that around one in five (19.9%) had symptoms of depression, compared to around two in five (40.1%) before the pandemic. Around one in 20 had had suicidal thoughts. Just over one in five (23.9%) reported seizures during the pandemic.

The study authors, Prof Jatinder Katyal and colleagues, found that seizures during the pandemic, increased seizure frequency, previous history of depression and changes to medicine regime were significantly linked with depression during the pandemic. Needing more than one epilepsy medicine, having seizures during the pandemic and a previous history of depression and suicidal thoughts were linked with people experiencing suicidal thoughts during the pandemic.

The researchers concluded that depression levels dropped significantly during the pandemic in their study group, despite other reports mostly finding an increase in anxiety and depression during this time. The reason for this isn’t clear, but the study authors suggested that lockdown may have provided a better support structure with things like taking medicines regularly, which may have contributed to lower depression levels. However, the researchers warned that conducting the follow-up interviews over the phone may have resulted in missed cases of depression.

The study authors called for restoring epilepsy services to pre-COVID levels, as well as putting in place continuity plans to help make this kind of care for people with epilepsy a priority.

There is more information about epilepsy and depression, including sources of support on the Epilepsy Action website.

Read the full story on the Epilepsy and Behavior website.


You may also be interested in...

Levetiracetam improves learning and memory in people with Alzheimer’s disease and epilepsy

Levetiracetam has been found to improve cognitive functions, like learning and memory, in people diagnosed with Alzheimer’s disease who also have epileptic brain activity, a study in Journal of the American Medical Association (JAMA) Neurology has found.

There are no comments yet. Be the first to comment...

Question about your epilepsy?

Your question will be sent to our helpline advisors.

Have a comment about this page?

All comments are reviewed by a moderator before publishing. Comments will be edited or deleted if they are offensive, libellous, slanderous, abusive, commercial or irrelevant.

We ask for your email when you make a comment through this website. This means that we can let you know directly that we have replied to you. By making a comment through the website, you allow us to use the comment in our publicity without using your name. If we would like to use your name, we will email you to get your permission.

The content of this field is kept private and will not be shown publicly.
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.